Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull

In particular, shareholders approved the election of all director nominees, the re-approval of Ernst & Young LLP as the Company's auditors and approving the unallocated shares, rights and other entitlements under the Company's share purchase plan.

Related Keywords

United States ,Canada ,America ,Harold Wolkin ,Christian Godin ,Cathy Steiner ,Arthur Deboeck ,Cipher Pharmaceuticals ,Cipher Pharmaceuticals Inc ,Company Board ,Ernst Young ,Health Canada ,John Mull ,North America ,Acne ,Bankruptcy ,Ceo ,Dividend ,Economy ,Financial Statements ,Food And Drug Administration ,Forward Looking Statement ,Manufacturing ,Merger And Acquisition ,Mergers And Acquisitions ,Pharmaceutical Industry ,Pharmaceuticals ,Articles ,Pharmaceutical Industry In China ,Regulations K ,Sec Rule 10b 5 ,